on 02 Jul 2024
Last Applicant/ Owned by
100 Stierli Court
Mt. Arlington
NJ
07856
Serial Number
98048406 filed on 19th Jun 2023
Registration Number
7432933 registered on 02th Jul 2024
Correspondent Address
Christine Amara
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
Software as a service (SaaS) services featuring software for use to assist in tracking and reporting healthcare practitioner and healthcare organization interactions and complying with international, federal, state and local spend and transparency laws and regulations; software as a service (SaaS) services featuring software to assist pharmaceutical, biotechnology and medical device companies in m Read More
Regulatory compliance consulting in the field of life sciences, pharmaceuticals, biotechnology, and medical devices; consulting services to assist life sciences, pharmaceutical, biotechnology and medical device companies in the fields of regulatory compliance, namely, compliance in the areas of aggregate spend disclosure reporting, the Prescription Drug Marketing Act, the Drug Supply Chain Security Act, Condition of Participation for Outpatient Services, Stark Law and Ohio Terminal Distributor of Dangerous Drugs requirements; regulatory compliance audits for life sciences, pharmaceutical, biotechnology and medical device companies to assist with regulatory compliance; consulting services in the field of life sciences, pharmaceutical, biotechnology and medical device corporate compliance program and transparency program development, implementation and support; providing online searchable databases and information concerning historical, current and pending laws, regulations, and guidance documents governing the life sciences industry; regulatory compliance consulting services in the field of aggregate spend disclosure reporting; regulatory and compliance information for pharmaceutical, biotechnology and medical device companies, and for entities involved in the drug and device supply chain, regarding transparency and aggregate spend, marketing, and additional compliance requirements; regulatory compliance consulting, namely, reviewing, developing, training on and assisting with the implementation and monitoring of standards, practices, procedures and policies to support regulatory compliance for companies in the fields of life sciences, pharmaceuticals, biotechnology, and medical devices
01st Apr 2021
01st Apr 2021
Software as a service (SaaS) services featuring software for use to assist in tracking and reporting healthcare practitioner and healthcare organization interactions and complying with international, federal, state and local spend and transparency laws and regulations; software as a service (SaaS) services featuring software to assist pharmaceutical, biotechnology and medical device companies in managing, validating and enriching healthcare organization and healthcare practitioner data attributes in connection with regulatory compliance, sales and marketing efforts
11th Feb 2003
11th Feb 2003
Consulting services in the nature of conducting trainings for life sciences, pharmaceuticals, biotechnology, and medical device companies personnel and partners on pharmaceutical and medical device compliance program requirements, fraud and corruption laws and regulations, industry codes and best practices; consulting services, namely, developing and providing trainings for life sciences, pharmaceutical, biotechnology, and medical device companies in the field of corporate compliance and transparency programs
01st Apr 2021
01st Apr 2021
Business consulting services for life sciences, pharmaceuticals, biotechnology and medical device companies in the nature of regulatory compliance program development and enhancement and transparency program support, namely, reviewing program status and performing gap analyses, drafting programs plans, program implementation support, development and improvement of policies, standard operating procedures and codes of conduct; business consulting services in the nature of monitoring of pharmaceutical and medical device manufacturer interactions with healthcare professionals, healthcare organizations, patients, and other customers; business consulting services in the nature of auditing of pharmaceutical and medical device manufacturer interactions with and payments to healthcare professionals, healthcare organizations, patients, and other customers; business consulting services in the nature of business investigation support for internally and externally raised complaints made against a pharmaceutical or medical device manufacturer related to potential violations of their company policy or code, industry code, or law or regulation; transparency reporting regulatory submission management, namely, assisting others in preparing and filing regulatory submissions in the field of transparency reporting for pharmaceutical, biotechnology and medical device companies; business consulting services, namely, tracking and monitoring regulatory requirements for others in the field of life sciences, pharmaceuticals, biotechnology, and medical devices for regulatory compliance; business consulting services, namely, compliance program gap analysis for life sciences, pharmaceutical, biotechnology, and medical device companies
01st Apr 2021
01st Apr 2021
No 98048406
No Service Mark
No
No
No
No
No
No
No
No
No
21.01.08 -
Jigsaw puzzles
26.11.21 -
Rectangles that are completely or partially shaded
Status Date | Action Taken |
---|---|
02th Jul 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
02th Jul 2024 | REGISTERED-PRINCIPAL REGISTER |
16th Apr 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
16th Apr 2024 | PUBLISHED FOR OPPOSITION |
27th Mar 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
11th Mar 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
05th Mar 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
05th Mar 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
05th Mar 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
01st Mar 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |